According to a recent LinkedIn post from Cytovale, implementation of its IntelliSep test at Froedtert Hospital, part of the Froedtert Hospital & the Medical College of Wisconsin Health Network, is associated with a 42% reduction in mortality among emergency department patients with suspected infection. The post directs viewers to an on-demand webinar featuring Dr. Thomas Carver and Dr. Nathan Ledeboer, who reportedly review clinical data, implementation lessons, and how earlier risk insight may support emergency department decision-making.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests growing real-world validation for IntelliSep in sepsis triage, which could strengthen Cytovale’s value proposition to hospitals focused on outcomes and cost of care. If similar results are replicated at additional sites, this type of data could support broader commercial adoption, potentially expanding recurring test volumes and enhancing Cytovale’s positioning in the sepsis diagnostics and emergency medicine workflow markets.

